Trial · NCT01925209
Adverse events564
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 564
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANAEMIA | Blood and lymphatic system disorders | BYM338/Bimagrumab 10 mg/kg | 5 | 63 | |
| other | ANAEMIA | Blood and lymphatic system disorders | BYM338/Bimagrumab 3 mg/kg | 3 | 63 | |
| other | ANAEMIA | Blood and lymphatic system disorders | BYM338/Bimagrumab 1 mg/kg | 0 | 63 | |
| other | ANAEMIA | Blood and lymphatic system disorders | Placebo | 1 | 62 | |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | BYM338/Bimagrumab 10 mg/kg | 3 | 63 | |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | BYM338/Bimagrumab 3 mg/kg | 4 | 63 | |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | BYM338/Bimagrumab 1 mg/kg | 0 | 63 | |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | Placebo | 0 | 62 | |
| other | ABDOMINAL PAIN UPPER | Gastrointestinal disorders | BYM338/Bimagrumab 10 mg/kg | 2 | 63 | |
| other | ABDOMINAL PAIN UPPER | Gastrointestinal disorders | BYM338/Bimagrumab 3 mg/kg | 6 | 63 | |
| other | ABDOMINAL PAIN UPPER | Gastrointestinal disorders | BYM338/Bimagrumab 1 mg/kg | 1 | 63 | |
| other | ABDOMINAL PAIN UPPER | Gastrointestinal disorders | Placebo | 0 | 62 | |
| other | CONSTIPATION | Gastrointestinal disorders | BYM338/Bimagrumab 10 mg/kg | 6 | 63 | |
| other | CONSTIPATION | Gastrointestinal disorders | BYM338/Bimagrumab 3 mg/kg | 3 | 63 | |
| other | CONSTIPATION | Gastrointestinal disorders | BYM338/Bimagrumab 1 mg/kg | 6 | 63 | |
| other | CONSTIPATION | Gastrointestinal disorders | Placebo | 3 | 62 | |
| other | DIARRHOEA | Gastrointestinal disorders | BYM338/Bimagrumab 10 mg/kg | 32 | 63 | |
| other | DIARRHOEA | Gastrointestinal disorders | BYM338/Bimagrumab 3 mg/kg | 28 | 63 | |
| other | DIARRHOEA | Gastrointestinal disorders | BYM338/Bimagrumab 1 mg/kg | 20 | 63 | |
| other | DIARRHOEA | Gastrointestinal disorders | Placebo | 11 | 62 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01925209/events